Rallybio Corporation

NASDAQ:RLYB

Biotechnology

Healthcare
$15.52 +0.03%

+$0.01 today

Market cap
$83.56M
Beta
-0.88
P/E (TTM)
-11.6
EPS (TTM)
-$1.37
52W Low $2.40High $17.57

Volume 0.04M

Average 0.25M

Cash Flow

Check whether earnings turn into cash.

Operating Cash Flow

-$29.81M

FY 2025 · Annual

Investing Cash Flow

$47.27M

FY 2025 · Annual

+41.1% YoY

Financing Cash Flow

$16,000.00

FY 2025 · Annual

-99.7% YoY

Cash Flow Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Net Income(47.01M)(66.65M)(74.56M)(57.78M)(8.98M)
Depreciation & Amortization109K167K150K131K92K
Deferred Income Tax00000
Stock-Based Compensation3.65M9.5M10.92M7.99M5.31M
Change in Working Capital(3.78M)(936K)4.28M(258K)(4.19M)
Accounts Receivables00000
Inventory00000
Accounts Payables(976K)487K(99K)(698K)(152K)
Other Working Capital(2.8M)(1.42M)4.38M440K(4.04M)
Other Non-Cash Items1.51M640K(1.05M)627K(22.05M)
Operating Cash Flow(45.53M)(57.28M)(60.27M)(49.28M)(29.81M)
Capital Expenditures(333K)(54K)(12K)00
Acquisitions (Net)(2M)(300K)(2.25M)(2M)0
Purchases of Investments(2M)(201.32M)(110.66M)(48.93M)(17.7M)
Sales of Investments2M89.5M138.33M84.43M46.47M
Other Investing Activities(2K)02.25M018.5M
Investing Cash Flow(2.33M)(112.17M)27.66M33.49M47.27M
Debt Repayment00000
Common Stock Issued86.2M51.53M143K5.41M16K
Common Stock Repurchased00000
Dividends Paid00000
Other Financing Activities(3.23M)(455K)0(206K)0
Financing Cash Flow82.97M51.08M143K5.2M16K
Effect of Forex Changes00000
Net Change in Cash35.1M(118.38M)(32.46M)(10.59M)17.47M
Free Cash Flow(45.87M)(57.34M)(60.28M)(49.28M)(29.81M)

Free Cash Flow

Net Income to FCF bridge

FY2025

= Net Income-$9.0M
+ D&A$92.0K
+ Stock-Based Comp$5.3M
+ Deferred Tax$0
- Working Capital-$4.2M
- Other Non-Cash-$22.0M
= Operating Cash Flow-$29.8M
- Capex$0
= Free Cash Flow-$29.8M

Analysis

FY2025 free cash flow is -$29.8M. FCF conversion is 332.1% of net income. Operating cash flow was -$29.8M, with capex of $0. The largest bridge item is Other Non-Cash at -$22.0M.

Recent Filings

Recent regulatory filings

FilingDescriptionDate
8-KCurrent reportNov 12, 2026
425425 filingNov 12, 2026
8-KCurrent reportNov 10, 2026
425425 filingNov 10, 2026
8-KCurrent reportNov 6, 2026

Does RLYB generate free cash flow?

Rallybio Corporation (RLYB) generated -$29.81M of free cash flow in fiscal 2025.

How much operating cash flow does RLYB produce?

Operating cash flow was -$29.81M, before capital expenditures of $0.00.